Skip to main content

Podoplanin (pdpn)

  • Reference work entry
  • First Online:
Book cover Encyclopedia of Signaling Molecules

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Astarita JL, Acton SE, Turley SJ. Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol. 2012;3:283. doi:10.3389/fimmu.2012.00283.

    Article  PubMed  PubMed Central  Google Scholar 

  • Atsumi N, Ishii G, Kojima M, Sanada M, Fujii S, Ochiai A. Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431. Biochem Biophys Res Commun. 2008;373(1):36–41.

    Article  CAS  PubMed  Google Scholar 

  • Caetano AS, Tjioe KC, Faustino SES, Hanemann JAC, Belone AFF, Soares CT, Oliveira DT. Immunolocalization of podoplanin in benign odontogenic tumours with and without ectomesenchyme. Arch Oral Biol. 2013;58(4):408–15.

    Article  CAS  Google Scholar 

  • Fernández-Muñoz B, Yurrita MM, Martín-Villar E, Carrasco-Ramírez P, Megías D, Renart J, Quintanilla M. The transmembrane domain of podoplanin is required for its association with lipid rafts and the induction of epithelial-mesenchymal transition. Int J Biochem Cell Biol. 2011;43(6):886–96. doi:10.1016/j.biocel.2011.02.010.

    Article  PubMed  CAS  Google Scholar 

  • Krishnan H, Ochoa-Alvarez JA, Shen Y, Nevel E, Lakshminarayanan M, Williams MC, Ramirez MI, Miller WT, Goldberg GS. J Biol Chem. 2013;288(17):12215–21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hata M, Ueki T, Sato A, Kojima H, Sawa Y. Expression of podoplanin in the mouse salivary glands. Arch Oral Biol. 2008;53(9):835–41.

    Article  CAS  PubMed  Google Scholar 

  • Nakazawa Y, Sato S, Naito M, Kato Y, Mishima K, Arai H, Tsuruo T, Fujita N. Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis. Blood. 2008;112:1730–9.

    Article  CAS  PubMed  Google Scholar 

  • Ohta M, Abe A, Ohno F, et al. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines. Oral Oncol. 2013;49(1):20–6. doi:10.1016/j.oraloncology.2012.06.017.

    Article  PubMed  CAS  Google Scholar 

  • Okamoto E, Kikuchi K, Miyazaki Y, González-Alva P, Oku Y, Tanaka A, Yoshida N, Fujinami M, Ide F, Sakashita H, Kusama K. Significance of podoplanin expression in keratocystic odontogenic tumor. J Oral Pathol Med. 2010;39:110–4. doi:10.1111/j.1600-0714.2009.00851.

    Article  PubMed  CAS  Google Scholar 

  • Pan Y, Wang WD, Yago T. Transcriptional regulation of podoplanin expression by Prox1 in lymphatic endothelial cells. Microvasc Res. 2014;94:96–102. doi:10.1016/j.mvr.2014.05.006.

    Article  PubMed  CAS  Google Scholar 

  • Renart J, Carrasco-Ramirez P, Fernandez-Munoz B, Martin-Villar E, Montero L, Yurrita MM, Quintanilla M. New insights into the role of podoplanin in epithelial-mesenchymal transition. In: Jeon KW, editor. International review of cell and molecular biology. San Diego: Academic; 2015. p. 189–90.

    Google Scholar 

  • Rodrigo JP, García-Carracedo D, González MV, Mancebo G, Fresno MF, García-Pedrero J. Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas. Mol Cancer. 2010;9:48. doi:10.1186/1476-4598-9-48.

    Article  PubMed  PubMed Central  Google Scholar 

  • Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong Y-K, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166(3):913–21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Swain N, Kumar S, Routray S, Pathak J, Patel S. Podoplanin – a novel marker in oral carcinogenesis. Tumour Biol. 2014;35(9):8407–13.

    Article  CAS  PubMed  Google Scholar 

  • Tsuneki M, Maruyama S, Yamazaki M, Essa A, Abé T, Babkair HA, Ahsan MS, Cheng J, Saku T. Podoplanin is a novel myoepithelial cell marker in pleomorphic adenoma and other salivary gland tumors with myoepithelial differentiation. Virchows Arch. 2013;462:297.

    Article  CAS  PubMed  Google Scholar 

  • Ugorski M, Dziegiel P, Suchanski J. Podoplanin – a small glycoprotein with many faces. Am J Cancer Res. 2016;6(2):370–86.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Wicki A, Christofori G. The potential role of podoplanin in tumour invasion. Br J Cancer. 2007;96:1–5. doi:10.1038/sj.bjc.6603518.

    Article  PubMed  CAS  Google Scholar 

  • Wu HM, Ren GX, Wang LZ, ZhangY CWT, Guo W. Expression of podoplanin in salivary gland adenoid cystic carcinoma and its association with distant metastasis and clinical outcomes. Mol Med Rep. 2012;6(2):271–4. doi:10.3892/mmr.2012.911.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samapika Routray .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Swain, N., Routray, S. (2018). Podoplanin (pdpn). In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101933

Download citation

Publish with us

Policies and ethics